Hachioji, Japan

Roxana Irimescu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Nippon Suisan Kaisha, Ltd.. Active years: 2005.


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Roxana Irimescu: Innovator in Lipase Technology

Introduction

Roxana Irimescu is a prominent inventor based in Hachioji, Japan. She has made significant contributions to the field of biochemistry, particularly in the production of glycerides using lipases. Her innovative approach has led to advancements in the efficiency and purity of triglyceride production.

Latest Patents

Roxana holds a patent for a process titled "Process for the production of glycerides with lipases." This invention provides a method for producing 2-monoglycerides (2-MG) or triglycerides (TG) with a focus on achieving extremely high purity and efficiency. The process involves conducting alcoholysis of a starting TG with a first 1,3-lipase to produce 2-MG. Subsequently, TG is generated by introducing fatty acid residues to the 1- and 3-positions of the produced 2-MG using a second 1,3-lipase. The fatty acid residue in the 2-position is preferably a residue of DHA, EPA, or ARA.

Career Highlights

Roxana is currently employed at Nippon Suisan Kaisha, Ltd., where she continues to develop her innovative processes. Her work has garnered attention for its potential applications in the food and pharmaceutical industries.

Collaborations

Roxana collaborates with notable colleagues, including Kiyomi Furihata and Kazuhiko Hata, who contribute to her research and development efforts.

Conclusion

Roxana Irimescu's contributions to lipase technology exemplify the impact of innovative thinking in biochemistry. Her patented process for glyceride production showcases her commitment to advancing the field and improving product quality.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…